• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于应用的围手术期抗凝治疗管理:POPACTApp 描述。

Application-based management of perioperative anticoagulant therapy: description of POPACTApp.

机构信息

Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

Institute for Multimedia and Interactive Systems, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

出版信息

Langenbecks Arch Surg. 2019 Aug;404(5):633-645. doi: 10.1007/s00423-019-01796-9. Epub 2019 Jun 17.

DOI:10.1007/s00423-019-01796-9
PMID:31209561
Abstract

PURPOSE

Perioperative management of oral anticoagulation (OAC) is a constant challenge in interventional and surgical procedures. When deciding to discontinue OAC, the risk of thromboembolic events must be balanced against the risk of bleeding during and after the planned procedure. These risks differ across patients and must be considered individually.

METHODS

POPACTApp, an application for the perioperative or peri-interventional management of oral anticoagulants, was developed using a human-centered design process (ISO 9241-210:2010). The treatment concept developed here can be adapted to a patient's individual risk profile. POPACTApp provides recommendations based on guidelines, consensus statements, and study data. After entering patient-specific risk factors, the attending physician using POPACTApp receives a clear and direct presentation of a periprocedural treatment concept, which should enable the efficient use of the program in everyday clinical practice. The perioperative treatment concept is presented via a timeline, including (1) the decision on whether to interrupt OAC, (2) the timing of the last preoperative administration of OAC in cases of interruption, (3) the decision on whether and how to bridge with heparins, and (4) the decision about when to reinitiate anticoagulation.

RESULTS

A task-based survey to evaluate POPACTApp's usability conducted with 20 surgeons showed that all clinicians correctly interpreted the recommendations provided by the app. Further, a questionnaire using a 7-point Likert scale from - 3 (negative) to + 3 (positive) revealed the following results to three specific questions: (1) satisfaction with the current standard procedure in the respective unit of the participant (0.15; SD = 1.57), (2) individual satisfaction with the POPACTApp application (2.7; SD = 0.47), and (3) estimation of the usefulness of POPACTApp for clinical practice (2.7; SD = 0.47).

CONCLUSIONS

POPACTApp provides clinicians with an individual risk-optimized treatment concept for the perioperative or peri-interventional management of OAC based on current guidelines, consensus statements, and study data, enabling the standardized perioperative handling of OAC in daily clinical practice.

摘要

目的

口服抗凝药物(OAC)的围手术期管理是介入和手术治疗中的一个持续挑战。在决定停止 OAC 治疗时,必须权衡血栓栓塞事件的风险与计划手术期间和之后出血的风险。这些风险因患者而异,必须个别考虑。

方法

POPACTApp 是一种用于口服抗凝药物围手术期或围介入期管理的应用程序,它是使用以人为中心的设计过程(ISO 9241-210:2010)开发的。这里开发的治疗概念可以根据患者的个体风险概况进行调整。POPACTApp 基于指南、共识声明和研究数据提供建议。输入患者特定的风险因素后,使用 POPACTApp 的主治医生会收到一个清晰、直接的围手术期治疗方案,这应该能够使其在日常临床实践中高效使用该程序。围手术期治疗方案通过时间线呈现,包括 (1) 是否中断 OAC 的决策,(2) 中断情况下最后一次术前 OAC 给药的时间,(3) 是否以及如何用肝素桥接的决策,和 (4) 何时重新开始抗凝的决策。

结果

一项针对 20 名外科医生进行的基于任务的调查,以评估 POPACTApp 的可用性,结果表明所有医生都正确地解释了该应用程序提供的建议。此外,一项使用 7 点李克特量表(-3 表示负面,+3 表示正面)的问卷调查显示,针对三个具体问题的结果如下:(1) 对参与者所在单位当前标准程序的满意度(0.15;SD=1.57),(2) 对 POPACTApp 应用程序的个人满意度(2.7;SD=0.47),和 (3) 对 POPACTApp 在临床实践中有用性的估计(2.7;SD=0.47)。

结论

POPACTApp 根据当前指南、共识声明和研究数据为 OAC 的围手术期或围介入期管理提供个体化风险优化的治疗方案,能够在日常临床实践中标准化地处理 OAC 的围手术期管理。

相似文献

1
Application-based management of perioperative anticoagulant therapy: description of POPACTApp.基于应用的围手术期抗凝治疗管理:POPACTApp 描述。
Langenbecks Arch Surg. 2019 Aug;404(5):633-645. doi: 10.1007/s00423-019-01796-9. Epub 2019 Jun 17.
2
Perioperative Management of Antiplatelet and Anticoagulant Therapy in Patients Undergoing Interventional Techniques: 2024 Updated Guidelines from the American Society of Interventional Pain Physicians (ASIPP).介入治疗患者围手术期抗血小板和抗凝治疗管理:美国介入疼痛医师学会(ASIPP)2024 年更新指南。
Pain Physician. 2024 Aug;27(S6):S1-S94.
3
Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.接受心脏设备植入的慢性口服抗凝治疗患者的围手术期抗凝管理:一项荟萃分析。
Pacing Clin Electrophysiol. 2014 Nov;37(11):1573-86. doi: 10.1111/pace.12517. Epub 2014 Sep 19.
4
Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.评估一种新的标准化方案用于围手术期管理接受植入式心脏心律失常装置的慢性抗凝患者。
Heart Rhythm. 2012 Mar;9(3):361-7. doi: 10.1016/j.hrthm.2011.10.010. Epub 2011 Oct 12.
5
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians.接受口服抗凝治疗患者的围手术期抗凝管理:临床医生实用指南
Thromb Res. 2002 Oct 1;108(1):3-13. doi: 10.1016/s0049-3848(02)00387-0.
6
Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines.介入技术治疗患者中抗血栓和抗凝药物的合理、安全、有效应用:美国介入疼痛医师学会(ASIPP)指南。
Pain Physician. 2019 Jan;22(1S):S75-S128.
7
Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.介入技术出血风险评估:抗凝和抗血栓治疗的实践模式和围手术期管理的最佳证据综合。
Pain Physician. 2013 Apr;16(2 Suppl):SE261-318.
8
Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.开发一种共享决策工具,以协助患者和临床医生就心房颤动的口服抗凝治疗做出决策。
Curr Med Res Opin. 2015 Dec;31(12):2261-72. doi: 10.1185/03007995.2015.1096767. Epub 2015 Oct 22.
9
Evaluation of a Standardized Perioperative Management Protocol in the Adult Hematology Anticoagulation Management Service.成人血液学抗凝管理服务中标准化围手术期管理方案的评估
Ann Pharmacother. 2017 Dec;51(12):1077-1083. doi: 10.1177/1060028017719505. Epub 2017 Jul 5.
10
Risk of thromboembolism with short-term interruption of warfarin therapy.华法林治疗短期中断后的血栓栓塞风险。
Arch Intern Med. 2008 Jan 14;168(1):63-9. doi: 10.1001/archinternmed.2007.23.

引用本文的文献

1
Effect of Standardized Perioperative Management on EEG Indexes and Nerve and Limb Functions of Patients with Acute Cerebral Infarction Undergoing Mechanical Thrombectomy.标准化围手术期管理对接受机械取栓的急性脑梗死患者的脑电图指标及神经和肢体功能的影响。
Dis Markers. 2022 Sep 26;2022:1686891. doi: 10.1155/2022/1686891. eCollection 2022.

本文引用的文献

1
Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.达比加群抗凝治疗患者出血及紧急侵入性操作管理:法国围手术期止血工作组(GIHP)更新指南-2016 年 9 月。
Anaesth Crit Care Pain Med. 2018 Aug;37(4):391-399. doi: 10.1016/j.accpm.2018.04.009. Epub 2018 May 2.
2
Acceptance of Using an Ecosystem of Mobile Apps for Use in Diabetes Clinic for Self-Management of Gestational Diabetes Mellitus.接受在糖尿病诊所使用移动应用程序生态系统进行妊娠期糖尿病自我管理。
Stud Health Technol Inform. 2017;245:188-192.
3
Description and Validation of TAVIApp: A Novel Mobile Application for Support of Physicians in the Management of Aortic Stenosis-Management of Aortic Stenosis with TAVIApp.
TAVIApp 的描述与验证:一种用于支持经导管主动脉瓣置换术管理主动脉瓣狭窄的新型移动应用程序-应用 TAVIApp 管理主动脉瓣狭窄。
Biomed Res Int. 2017;2017:9027597. doi: 10.1155/2017/9027597. Epub 2017 Nov 15.
4
Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial.用于预防2型糖尿病的移动健康技术(mDiab):一项随机对照试验的方案
JMIR Res Protoc. 2017 Dec 12;6(12):e242. doi: 10.2196/resprot.8644.
5
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):616-664. doi: 10.1093/ejcts/ezx324.
6
A pilot intervention to reduce postpartum weight retention and central adiposity in first-time mothers: results from the mums OnLiNE (Online, Lifestyle, Nutrition & Exercise) study.一项旨在减少初产妇产后体重滞留和中心性肥胖的初步干预措施:来自 mums OnLiNE(在线、生活方式、营养和运动)研究的结果。
J Hum Nutr Diet. 2018 Jun;31(3):314-328. doi: 10.1111/jhn.12521. Epub 2017 Oct 16.
7
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.2017 年美国心脏病学会专家共识决策路径:非瓣膜性心房颤动患者抗凝治疗围术期管理:美国心脏病学会临床专家共识文件工作组的报告。
J Am Coll Cardiol. 2017 Feb 21;69(7):871-898. doi: 10.1016/j.jacc.2016.11.024. Epub 2017 Jan 9.
8
Clinical Usefulness of a Mobile Application for the Appropriate Selection of the Antiarrhythmic Device in Heart Failure.一款用于心力衰竭患者抗心律失常装置合理选择的移动应用程序的临床实用性
Pacing Clin Electrophysiol. 2016 Jul;39(7):696-702. doi: 10.1111/pace.12872. Epub 2016 May 19.
9
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.更新的欧洲心脏节律协会实用指南:非维生素 K 拮抗剂抗凝剂在非瓣膜性心房颤动患者中的应用。
Europace. 2015 Oct;17(10):1467-507. doi: 10.1093/europace/euv309. Epub 2015 Aug 31.
10
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.心房颤动患者围手术期的桥接抗凝治疗
N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.